Key facts
- Seven Starling’s last known valuation is $49.0M (Sep 2025).
- It has raised $25.3M; the latest was Later Stage VC ($8.0M) in Sep 2025.
- Notable investors include Dorm Room Fund, Harvard Innovation Launch Lab, Pear (California), Emerson Collective, Ulu Ventures — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Seven Starling
- ·The full record, as it builds
Funding rounds
No funding rounds for Seven Starling are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Seven Starling
Developer of an online healthcare platform designed to offer women's behavioral health services. The company's platform provides specialized mental health care that supports the pivotal stages of fertility, pregnancy, loss, and early motherhood, enabling young parents with support at every stage of pregnancy and child development.
- Sector
- Healthcare
- HQ
- Washington, DC, United States
- Founded
- 2020
- Employees
- 48
- Website
- sevenstarling.com/
- Ownership
- Privately Held (backing)
Seven Starling doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Seven Starling shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Seven Starling in its N-PORT filings yet. We sweep new filings monthly.